Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SIMEOX 200 Airway Clearance Device, expanding the company’s ability to market and meet the various needs of patients with chronic respiratory diseases in the U.S.
Breakthrough research identifies pathway used by glioblastoma to infiltrate the brain
A new pathway that is used by cancer cells to infiltrate the brain has been discovered by a team of Canadian and American research groups
August 2, 2024